Search results for “Signal peptidase” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 217 patents, we discovered top 31 key players by total patent application. RQx Pharmaceuticals, Inc., Genentech, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 81.11% of the total patent filing.
RQx Pharmaceuticals, Inc.
California, United States
Patent: 92
Genentech, Inc.
California, United States
Patent: 64
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 20
Shanghai Biowindow Gene Development Co. Ltd.
Shanghai Shi, China
Patent: 20
Merck Canada, Inc.
Canada
Patent: 11
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 10
AbbVie, Inc.
Illinois, United States
Patent: 7
Abbott Laboratories
Illinois, United States
Patent: 6
Mitsui Chemicals, Inc.
Tokyo-to, Japan
Patent: 5
Cornell Research Foundation, Inc.
New York, United States
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 69 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Genentech, Inc., RQx Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. take 128.99% of patent filing during this period.
Genentech, Inc.
California, United States
Patent: 36
RQx Pharmaceuticals, Inc.
California, United States
Patent: 33
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 20
University of Melbourne
Victoria, Australia
Patent: 2
The Scripps Research Institute
California, United States
Patent: 1
Shengming Biotechnology (Zhengzhou) Co., Ltd.
Henan Sheng, China
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
undefined undefined
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 69 patents in last 5 years, we discover 8 new entrants. F. Hoffmann-La Roche Ltd., University of Melbourne, Shengming Biotechnology (Zhengzhou) Co., Ltd. are the most active new entrants in this area.
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 20
University of Melbourne
Victoria, Australia
Patent: 2
Shengming Biotechnology (Zhengzhou) Co., Ltd.
Henan Sheng, China
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences
undefined undefined
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 42 patents, we discovered top 9 universities and scientific research institutions by total patent application. The Scripps Research Institute, Vanderbilt University, University of Melbourne are dominant in this area. They take 73.81% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 23
Vanderbilt University
Tennessee, United States
Patent: 3
University of Melbourne
Victoria, Australia
Patent: 2
Jiangnan University
Jiangsu Sheng, China
Patent: 2
Cornell University
New York, United States
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 1
Tianjin University
Tianjin Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: